Yu Bin, Li MengYuan, Huang HaiPeng, Ma ShiQi, Huang Ke, Zhong Zhen, Yu Shuo, Zhang LiYing
Changchun University of Chinese Medicine, Changchun Jilin, China.
J Clin Pharm Ther. 2021 Jun;46(3):585-598. doi: 10.1111/jcpt.13351. Epub 2021 Jan 28.
To evaluate the clinical efficacy of acupuncture through a review and analysis of systematic reviews of acupuncture for the treatment of diabetic peripheral neuropathy.
Systematic reviews of acupuncture treatment for diabetic peripheral neuropathy were collected by searching CNKI, VIP, Wanfang database, Chinese Biomedical Literature Database (CBM), PubMed, Web of Science and the Cochrane Library. The retrieval period was from the establishment of the database to February 14, 2020. After literature selection and extraction, included reports were evaluated in terms of the quality of the methodology and of the report using criteria from the AMSTAR2 scale and the PRISMA statement.
Eighty eight reviews were retrieved. The inclusion criteria were a published systematic evaluation/meta-analysis/systematic review of acupuncture treatment for diabetic peripheral neuropathy, which included subjects meeting the diagnostic criteria for diabetic peripheral neuropathy, and which compared acupuncture treatment with non-acupuncture treatment. After the inclusion criteria had been applied, 18 reviews were finally included. According to the PRISMA statement, 3 reports were relatively complete, 12 reports had certain defects, 3 reports had considerable information missing, and 18 reports had extremely low methodological quality according to the AMSTAR2 scale. Current evidence shows that acupuncture improves diabetic peripheral neuropathy and increases nerve conduction velocity. However, the methodological quality of the reviews is generally extremely low, and most of the reviews had certain defects, showing that there is still much room for improvement in terms of the methodology and quality of the research reports.
Acupuncture appears to have an effect on DPN, effectively improving nerve conduction and clinical symptoms. Although the methodological quality of the included studies was generally very low and defects were frequent, our study highlights areas where improvement in methodology is required. There is a need for further study of the pathogenesis of DPN, and for developing a unified standard for methods of acupuncture treatment, acupoint selection, and adverse reactions reporting. Traditional Chinese medical practices such as acupuncture should adopt an evidence-based approach to provide greater confidence in their use.
通过对针刺治疗糖尿病周围神经病变的系统评价进行回顾和分析,评估针刺的临床疗效。
通过检索中国知网、维普、万方数据库、中国生物医学文献数据库(CBM)、PubMed、Web of Science和Cochrane图书馆,收集针刺治疗糖尿病周围神经病变的系统评价。检索时间范围为各数据库建库至2020年2月14日。经过文献筛选和提取后,采用AMSTAR2量表和PRISMA声明的标准,从方法学质量和报告质量方面对纳入的报告进行评价。
共检索到88篇综述。纳入标准为已发表的关于针刺治疗糖尿病周围神经病变的系统评价/荟萃分析/系统综述,其中包括符合糖尿病周围神经病变诊断标准的受试者,且将针刺治疗与非针刺治疗进行了比较。应用纳入标准后,最终纳入18篇综述。根据PRISMA声明,3篇报告相对完整,12篇报告存在一定缺陷,3篇报告有大量信息缺失,根据AMSTAR2量表,18篇报告的方法学质量极低。目前的证据表明,针刺可改善糖尿病周围神经病变并提高神经传导速度。然而,综述的方法学质量普遍极低,且大多数综述存在一定缺陷,表明研究报告的方法学和质量仍有很大的改进空间。
针刺似乎对糖尿病周围神经病变有作用,可有效改善神经传导和临床症状。尽管纳入研究的方法学质量普遍很低且缺陷频繁,但我们的研究突出了需要改进方法学的领域。需要进一步研究糖尿病周围神经病变的发病机制,并制定针刺治疗方法、穴位选择和不良反应报告的统一标准。针刺等中医实践应采用循证医学方法,以增强其应用的可信度。